Sidebar

Navigation

CEE Legal Matters In-depth coverage of the news and newsmakers that shape Europe's emerging markets

26

Fri, Jul

78 New Articles

Turunc Advises Pollet Medical Group on Approval for Acquisition of Farmasol

Turunc Advises Pollet Medical Group on Approval for Acquisition of Farmasol

Turunc Advises Pollet Medical Group on Approval for Acquisition of Farmasol

Turkiye

Tools

Print

Typography

Smaller Small Medium Big Bigger
Default Helvetica Segoe Georgia Times
Reading Mode

Turunc has advised Pollet Medical Group on obtaining the approval of the Turkish Competition Board for the majority acquisition of Farmasol.

Pollet Medical Group is a Belgium-based provider of medical services and solutions for the healthcare industry.

Farmasol is a specialty pharmaceutical company.

The Turunc team included Founding Partner Noyan Turunc, Partner Esin Camlibel, and Associates Naz Esen and Beste Yildizili Ergul.